Proposed Board Appointment

Belluscura PLC
26 May 2023
 

 

Belluscura plc

("Belluscura", the "Company" or the "Group")

Proposed Board Appointment

 

Further to the announcement at 11:00 a.m on 25 May 2023 ("Fundraising Announcement") the following information is notified in relation to Bob Fary, currently the Group's VP of Global Sales. It is proposed that Mr Fary will join the board as an Executive Director subject to satisfactory completion of the requisite due diligence and nominated adviser checks.

Full name: Robert (Bob) Sylvester Fary

Age: 65 years old

Mr Fary currently holds the following directorships/partnerships:

None

Directorships and partnerships held within the last five years:

American Associate for Homecare

Mr Fary currently holds 400,000 options in the Company. As notified in the Fundraising Announcement he has subscribed for 32,000 new ordinary shares in the Subscription.

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 **ENDS**

 For further information please contact:

 

Belluscura plc

www.belluscura.com

Adam Reynolds, Non-Executive Chairman

via MHP

Robert Rauker, Chief Executive Officer


Anthony Dyer, Chief Financial Officer


 


SPARK Advisory Partners Limited (Nominated Adviser)

Tel: +44 (0)20 3368 3550

Neil Baldwin


 


Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

James Serjeant / Russell Cook / Nicholas Chambers




MHP (Financial PR & Investor Relations)

Tel: +44 (0)20 3128 8100

Katie Hunt / Pete Lambie / Matthew Taylor

email: belluscura@mhpgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Belluscura (BELL)
UK 100

Latest directors dealings